← Open Payments lookup

ANGELA TONG-MULKERN: Open Payments

NPI 1740055920 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$570 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $405 · 2025 $570

Food & beverage: $570
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$105
Alkermes, Inc.4$88
Vanda Pharmaceuticals Inc.4$86
Lundbeck LLC3$74
Axsome Therapeutics, Inc.2$49
Janssen Pharmaceuticals, Inc2$49
E.R. Squibb & Sons, L.L.C.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33
Otsuka Pharmaceutical Development & Commercialization, Inc.1$26
ABBVIE INC.1$26

Products named: REXULTI, FANAPT, ARISTADA, COBENFY, CAPLYTA, SPRAVATO, REJOYN, VRAYLAR.

Industry payments across MA — which companies pay providers there.